News Column

Endocan Gives Shareholder Guidance for Its Medicine Dispensing Systems (MDS) Multi-Million Dollar Agreement for Multi-State Product Release...

February 6, 2014

Endocan Gives Shareholder Guidance for Its Medicine Dispensing Systems (MDS) Multi-Million Dollar Agreement for Multi-State Product Release Licensing , Medical Cannabis Dispensary Management, and Cultivation Management Endocan Corp. , a U.S. Company specializing in cannabis and cannabinoid formulation-based health and wellness solutions, announced that it provides shareholder guidance concerning its consultant MDS, a subsidiary of Medbox, Inc. , and the multi-million dollar agreement for multi-state product release licensing, medical cannabis dispensary management, and cultivation. "We are excited by the renewed energy with MDS. Endocan looks forward to moving forward with the executives at MDS as an industry leader in consulting and helping match entrepreneurs with opportunities," stated Robert Kane , CFO and SR VP of Business Development, Endocan Corp. " Endocan is positioned well to take advantage of these opportunities." As announced on August 20, 2013 , Endocan noted that it will be bringing proprietary cannabinoid-based products and formulations to market in state-approved regulatory environments with dispensaries to be branded by the Company while using the patented ' Medbox ' dispensing technology. Endocan's multi-year, strategic growth agreement with Medicine Dispensing Systems, a subsidiary of Medbox , a publicly traded company, establishes Endocan as the provider of scientific and clinical experience for multiple medical cannabis dispensaries and cultivation facilities in the states of Arizona , California , Illinois , Massachusetts , Nevada , and Washington State . This milestone agreement provides Endocan with the real and concrete opportunity to develop premiere branding and to introduce the Company's proprietary cannabinoid-based products and formulations within each state's regulatory framework. Under the agreement, as a part of each dispensary build-out, Endocan will brand the operations through the use of the patented Medbox system. Medbox technology and software allows for biometric patient and employee identification, internal documentation and tracking of dispensing services for internal accounting and compliance purposes, and secure inventory management and control. Medbox was founded on the principle that all great industries thrive when automated and regulated. Endocan's subsidiary, Medicine Dispensing Systems has grossed $13 million dollars since it began doing business in 2010 and later allowed for an acquisition and the establishment of a public company presence in Medbox, Inc. [MDBX]. The company's founder and CEO have appeared in interviews with CNN, ABCNews, Reuters, BBC , Fox Business, Bloomberg TV, CNBC , Associated Press , NPR , and the company has been featured in articles appearing in Newsweek, Bloomberg BusinessWeek , Los Angeles Times , Chicago Tribune , and the Wall Street Journal , as well as over 30 other news agencies around the world concerning its products and services. More Information: endocan.com ((Comments on this story may be sent to newsdesk@closeupmedia.com ))


For more stories on investments and markets, please see HispanicBusiness' Finance Channel



Source: Professional Services Close - Up


Story Tools